When it comes to health
We see things others don’t.
Building a world where people don’t have to become patients.
We believe the keys to our future health lie within us. We are convinced that predictive, contextual, actionable health insights can be used to prevent disease and transform healthcare. And we believe that only by tackling the biggest challenges in healthcare can we bring about real, lasting change in people’s lives. We are starting with the opioid crisis.
By combining genetic data with machine learning and custom algorithms, we discover biological signals that lead to better health.
Our goal is to prevent disease by making actionable and contextual health information available to patients and their healthcare providers.
We call this approach Patient Intelligence. It empowers individuals and clinicians to make better decisions, based on objective, actionable information.
Already, two of our innovations have received Breakthrough Device designations from the FDA. This classification is given to products that represent breakthrough technology, which may provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating conditions for which no approved or cleared alternatives exist, and are in patients’ best interest.
We’ve found unique ways to bring data technology solutions into the lives of patients. Founded by a physician, we understand the challenges of doing healthtech right. We are science-forward and committed to building products based on robust data, thorough clinical studies, and full compliance with regulatory processes.
Partner with Us
If you are a provider, a payer, a healthcare system, or a researcher and are interested in working with us, we’d love to talk.
Read Our Latest Blog
Just as your genes determine the basic truths of your biology—things like your height and eye and hair color—genes also determine how your body reacts to certain medications. No medication works the same for everyone; in fact, results can vary widely.
FDA Breakthrough Device designation is granted to novel medical devices that have the potential to provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.
As the U.S. continues to battle the national public health crisis presented by the COVID-19 global pandemic, our nation’s ongoing opioid epidemic is worsening. During the first three months of 2020, drug overdose fatalities increased by roughly 10%.